CRL: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling $3K and 1 sales totaling $303K in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 15 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Coleman Glenn | CFO | 2026-09-30 | $3K | 0% |
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-05 | Parisotto Shannon M | Officer | $303K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-08 | 13G stake raised | FMR LLC | 10.20% | +1.40 pts | SEC |
| 2026-08-13 | New 13G stake | Invesco Ltd. | 6.20% | SEC | |
| 2026-08-06 | 13G amendment | FMR LLC | 8.80% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.